Vice-Chairman of Surgery Deputy Director, MD Anderson Cancer Center at Cooper Head, Division of General Surgery Professor, Cooper Medical School at Rowan University Adjunct Professor, MD Anderson Cancer Center
General Surgery
Dr. Francis R. Spitz, MD
|
|
Give Review
Francis R. Spitz is an expert in the field of General Surgery. He attended University of Connecticut School of Medicine. University of Connecticut School of Medicine has a rank of 60 in research and a 49 in primary care He received 4 awards: "Inside Jersey Magazine Top Doctors", "Inside Jersey Top Doctors for Cancer", "Philadelphia Magazine" and "Fellow (FACS)". Dr. Francis R. Spitz is a published MD as well. He has 50 publications published. The latest was: Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Francis R. Spitz is registered with Medicare.
Publications
- Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leu...
- Postoperative mortality after esophagectomy for Cancer: development of a preoperative risk prediction model.
- Time of day is associated with postoperative morbidity: an Analysis of the national surgical quality improvement program data.
- Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase Melanomas: a case for SLN Staging biopsy in these ...
- Identification of high-risk patients among those diagnosed with thin cutaneous Melanomas.
- Targeting HER-2/neu in early breast Cancer development using dendritic cells with staged interleukin-12 burst secretion.
- HIV protease inhibitor nelfinavir inhibits growth of human melanoma Cells by induction of Cell cycle arrest.
- Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-Cell migration toward melanoma Cells.
- Use of radiotracer for sentinel lymph node mapping in breast Cancer optimizes staging independent of site of administration.
- Predictors of regional nodal disease in patients with thin Melanomas.
- Should all Melanoma patients undergo sentinel lymph node biopsy?
- AKT activation and response to interferon-beta in human Cancer cells.
- Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin Melanomas.
- Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established coloRectal liver metastases.
- Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human Cancer ce...
- Changes in the surgical management of patients with breast Carcinoma based on preoperative magnetic resonance imaging.
- Intraperitoneal photodynamic therapy causes a capillary-leak syndrome.
- Magnetic resonance imaging-guided biopsy of mammographically and clinically occult Breast lesions.
- Subareolar and peritumoral injection identify similar sentinel nodes for breast Cancer.
- Myotube-specific activity of the human aldolase A M-promoter requires an overlapping binding site for NF1 and MEF2 factors in addition to a binding site (M1) for unkno...
- High levels of gene transDuction in human lung tumors following intralesional injection of recombinant adenovirus.
- Intraoperative radiotherapy in the combined-modality management of pancreatic Cancer.
- The alpha subunits of Gz and Gi interact with the eyes absent transcription cofactor Eya2, preventing its interaction with the six class of homeodomain-containing prot...
- Gene therapy for lung Cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer.
- Primary pancreatic Lymphoma.
- Role of conservation therapy for invasive lobular Carcinoma of the breast.
- Adjuvant and neoadjuvant chemoradiation therapy for primary colorectal Cancer.
- Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung Cancer cells.
- Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung Cancer cells.
- Viral and nonviral gene delivery vectors for Cancer gene therapy.
- Hemangiopericytoma: a 20-year single-institution experience.
- In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal Cancer.
- Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal Cancer cells to ionizing radiation.
- Intra-arterial delivery of a recombinant adenovirus does not increase gene transfer to tumor cells in a rat model of metastatic coloRectal carcinoma.
- Systemic IFN-beta gene therapy results in long-term survival in mice with established coloRectal liver metastases.
- Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast Carcinoma.
- p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal Cancer.
- Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenoCarcinoma of the pancreas.
- Gene therapy of metastatic disease: progress and prospects.
- Incidence of sentinel node metastasis in patients with thin primary Melanoma (< or = 1 mm) with vertical growth phase.
- 99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in Melanoma.
- Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis.
- Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal Tumors.
- A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal Carcinomatosis and sarcomatosis.
- Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.
- Interferon-beta gene therapy improves survival in an immunocompetent mouse model of Carcinomatosis.
- Time-of-day effects on surgical outcomes in the private sector: a retrospective cohort study.
- Underuse of esophagectomy as treatment for resectable esophageal Cancer.
- Gene therapy for Cancer and metastatic disease.
Schools
Univ Of Ct Sch Of Med
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Surgical Oncology
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Local Value Network EPO
- Local Value Network HMO
- Local Value Network HMO+
- Local Value Network POS+
- Local Value Network PPO
- Personal Choice PPO
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Advance EPO
- Direct Access
- Horizon Blue Cross Blue Shield HMO
- Horizon Blue Cross Blue Shield POS
- Horizon Blue Cross Blue Shield PPO
- Choice Care PPO
- Keystone Health Plan East HMO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- QualCare HMO
- QualCare PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- Inside Jersey Magazine Top Doctors
- Inside Jersey Top Doctors for Cancer
- Philadelphia Magazine
- Fellow (FACS)
Education
-
Thomas Jefferson University -
University of Connecticut School of Medicine
Hospital
-
Cooper University Health Care
Drug Facts
| NPI NUMBER | 1548360530 | |
| NPPES Provider LastName | SPITZ | |
| NPPES Provider FirstName | FRANCIS | |
| NPPES Provider ZIPCode | 081031438 | |
| NPPES Provider State | NJ | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 113.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 9.73 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548360530 |
| Last Name Of The Provider | SPITZ |
| First Name Of The Provider | FRANCIS |
| View All |
Similar Doctors
|
Helen C. Hall |
|
Dr. Frank C. Koniges, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Umur M. Atabek, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Dennis J. Hoelzer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nadine Barth, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey P. Carpenter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kristin L. Brill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin R. Phillips, MD
This Doctor is OpenDoctor Recommended.
|